Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Biotech
Biotech
Page 4 of 19
Newsletters
A.I.-fueled biotech startups are having a moment—and one just raised $300 million in a Series A
By
Lucy Brewster
May 23, 2023
Health
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By
Arthur Allen
and
KFF Health News
April 13, 2023
Tech
The Silicon Valley Bank meltdown could be a disaster for downtrodden biotech startups
By
Angelica Peebles
,
Ilena Peng
and
Bloomberg
March 10, 2023
Tech
The 11 most promising health tech startups, according to Silicon Valley VCs
By
Lucy Brewster
October 24, 2022
Tech
Health Tech startups are booming. These 11 VC investors are behind some of the hottest deals
By
Lucy Brewster
September 23, 2022
Finance
Biden’s new executive order triggers new front in U.S.-China economic competition
By
Tristan Bove
September 12, 2022
Biden to spur biomanufacturing, reduce reliance on China with executive order
By
Riley Griffin
and
Bloomberg
September 10, 2022
Health
Parents are becoming drug developers to find a cure for their children’s rare diseases
By
Jared Whitlock
and
Kaiser Health News
July 21, 2022
Commentary
ESG investors shouldn’t ignore biotech’s potential to deliver change
By
Michelle McMurry-Heath
May 2, 2022
Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By
Sy Mukherjee
and
IDEA Pharma
April 20, 2022
Finance
Investors are moving away from biotech stocks as COVID wanes
By
Angelica Peebles
and
Bloomberg
February 14, 2022
Health
Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
By
Jeremy Kahn
January 7, 2022
Health
Omicron vaccine to begin clinical trial in South Africa
By
Jeremy Kahn
December 6, 2021
Magazine
Moderna’s COVID vaccine success made the stock a big pandemic winner. Will the run continue?
By
Rey Mashayekhi
December 2, 2021
Tech
DeepMind spins out new Alphabet company focused on drug discovery
By
Jeremy Kahn
November 4, 2021
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
AI
Meta’s 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is ‘vibe coding’ right now
By
Eva Roytburg
Success
As graduates face a ‘jobpocalypse,’ Goldman Sachs exec tells Gen Z they need to know their commercial impact
By
Preston Fore